http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-027153-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9113643aaf38097240bdcb14fe964d08 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 |
| filingDate | 2000-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-027153-A1 |
| titleOfInvention | OXIBUTININE MULTITABLE SYSTEM FOR THE TREATMENT OF INCONTINENCE |
| abstract | A multitableta system is provided for the treatment of urinary incontinence with oxybutynin. A particular embodiment provides a first tablet that releases oxybutynin for a short period of time, for example, less than 6 hours and a second tablet that releases oxybutynin for an extended period of time, for example, 18 to 24 hours, to maintain therapeutically effective levels of Oxybutynin in mammals for a period of about 24 hours. Unlike other systems, this system is easily adaptable to compensate for variability among patients in response to Conoxibutinin therapy. A method of treatment of urinary incontinence is provided with the aforementioned system and a kit comprising several first and second stages to quickly develop a dosage regimen adapted to the patient, for example, the dosage regimen that provides the greatest therapeutic and / or therapeutic benefit. or the lower number or the lower severity of secondary effects. This system causes fewer side effects than conventional single tablet systems that provide approximately the same therapeutic dose. |
| priorityDate | 2000-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4634 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502831 |
Total number of triples: 19.